Dietary anaplerotic therapy improves peripheral tissue energy metabolism in patients with Huntington's disease-Reference-Cited by-同舟云学术

Dietary anaplerotic therapy improves peripheral tissue energy metabolism in patients with Huntington's disease

Published:2010-05-26 Issue:9 Volume:18 Page:1057-1060
ISSN:1018-4813
Container-title:European Journal of Human Genetics
language:en
Short-container-title:Eur J Hum Genet

Author:

Mochel Fanny,Duteil Sandrine,Marelli Cécilia,Jauffret Céline,Barles Agnès,Holm Janette,Sweetman Lawrence,Benoist Jean-François,Rabier Daniel,Carlier Pierre G,Durr Alexandra

Publisher

Springer Science and Business Media LLC

Subject

Genetics(clinical),Genetics

Link

http://www.nature.com/articles/ejhg201072.pdf

Reference19 articles.

1. Mochel F, Charles P, Seguin F et al: Early energy deficit in Huntington disease: identification of a plasma biomarker traceable during disease progression. PLoS One 2007; 2: e647.

2. De Bandt JP, Cynober L : Therapeutic use of branched-chain amino acids in burn, trauma, and sepsis. J Nutr 2006; 136: 308S–313S.

3. Roe CR, Mochel F : Anaplerotic diet therapy in inherited metabolic disease: therapeutic potential. J Inherit Metab Dis 2006; 29: 332–340.

4. Mochel F, DeLonlay P, Touati G et al: Pyruvate carboxylase deficiency: clinical and biochemical response to anaplerotic diet therapy. Mol Genet Metab 2005; 84: 305–312.

5. Duteil S, Bourrilhon C, Raynaud JS et al: Metabolic and vascular support for the role of myoglobin in humans: a multiparametric NMR study. Am J Physiol Regul Integr Comp Physiol 2004; 287: R1441–R1449.

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Triheptanoin Did Not Show Benefit versus Placebo for the Treatment of Paroxysmal Movement Disorders in Glut1 Deficiency Syndrome: Results of a Randomized Phase 3 Study;Movement Disorders;2024-05-09

2. Modulators of ASIC1a and its potential as a therapeutic target for age-related diseases;Ageing Research Reviews;2023-01

3. Lipid metabolism in neurodegenerative diseases;Cellular Lipid in Health and Disease;2023

4. Triheptanoin as a nutraceutical and its potential use in epilepsy;Treatments, Nutraceuticals, Supplements, and Herbal Medicine in Neurological Disorders;2023

5. Boosting mitochondrial health to counteract neurodegeneration;Progress in Neurobiology;2022-08